JENNIFER COURTOUISE: Open Payments
NPI 1265140263 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 56 payments from 20 companies in 2025. Trend: 2023 $94 · 2024 $803 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $172 |
| Radius Health, Inc. | 5 | $139 |
| Otsuka America Pharmaceutical, Inc. | 5 | $114 |
| Novo Nordisk Inc | 3 | $66 |
| PFIZER INC. | 3 | $54 |
| Exact Sciences Corporation | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
Products named: REXULTI, Tymlos, VRAYLAR, UBRELVY, JARDIANCE, NEXLETOL, CAPLYTA, BREZTRI.
Industry payments across MO — which companies pay providers there.
